INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 CONCENTRATIONS AND INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 PROTEASE ACTIVITY IN SERA OF PATIENTS WITH MALIGNANT SOLID TUMORS OR LEUKEMIA

被引:0
|
作者
MULLER, HL
OH, Y
GARGOSKY, SE
WILSON, KF
LEHRNBECHER, T
ROSENFELD, RG
机构
[1] STANFORD UNIV,SCH MED,MED CTR,DEPT PEDIAT,DIV PEDIAT ENDOCRINOL,STANFORD,CA 94305
[2] UNIV WURZBURG,KINDERKLIN,D-97080 WURZBURG,GERMANY
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
IGF binding proteins (IGFBP) regulate the bioavailability and bioactivity of IGF. The major IGFBP in serum is IGFBP-3. We investigated whether sera from children with malignancies show alterations in levels of IGFBP-3 as measured by Western ligand blot analysis (WLB) and RIA with alpha IGFBP-3gl, a specific rabbit polyclonal antibody. Furthermore, IGFBP-3 proteolysis was quantified by densitometric analysis of[I-125]IGFBP-3 protease assays, and IGFBP-3 fragments were visualized by Western immunoblot with alpha IGFBP-3gl. We examined sera from 21 children with solid tumors, five patients with sarcoma who had reached complete remission, and 13 children with acute leukemia. Serum samples were collected at diagnosis, before initiation of therapy. Sera of 10 healthy children served as normal controls. Children with solid tumor or leukemia had significantly higher (p < 0.001) IGFBP-3 protease activity in serum than did normal controls or patients with sarcoma in complete remission. Corresponding to this finding, densitometry of WLB showed lower IGFBP-3 levels in sera of children with malignancies in comparison with normal controls. The negative correlation (p < 0.001, r = -0.80) between IGFBP-3 proteolysis, as measured by [I-125]IGFBP-3 protease assay, and IGFBP-3 band density on WLB indicates that proteolysis is the probable reason for reduction of IGFBP-3 on WLB. IGFBP-3 concentrations measured by RIA were in the normal range for most patients, further indicating that differences in serum IGFBP-3 levels measured by WLB reflect protease activity. We conclude that sera from children with malignancies frequently contain protease activity that causes IGFBP-3 cleavage in a way that might affect the tissue availability of IGF. Because many tumor cells are responsive to the mitogenic actions of IGF in vitro, IGFBP-3 proteases in serum could also play a role in tumor progression and metastasis in vivo.
引用
收藏
页码:720 / 724
页数:5
相关论文
共 50 条
  • [41] Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer
    Duggan, Catherine
    Wang, Ching-Yun
    Neuhouser, Marian L.
    Xiao, Liren
    Smith, Ashley Wilder
    Reding, Kerryn W.
    Baumgartner, Richard N.
    Baumgartner, Kathy B.
    Bernstein, Leslie
    Ballard-Barbash, Rachel
    McTiernan, Anne
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (05) : 1191 - 1200
  • [42] BIOSYNTHESIS OF INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING PROTEIN-3 BY PRIMARY CULTURED HUMAN HEPATOCYTES
    SCHMIDTSANDTE, W
    SCHARF, JG
    PAHERNIK, SA
    RAMADORI, G
    KOEBE, HG
    HARTMANN, H
    HEPATOLOGY, 1994, 20 (04) : A224 - A224
  • [43] Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 in Alzheimer's Disease
    Duron, Emmanuelle
    Funalot, Benoit
    Brunel, Nadege
    Coste, Joel
    Quinquis, Laurent
    Viollet, Cecile
    Belmin, Joel
    Jouanny, Pierre
    Pasquier, Florence
    Treluyer, Jean-Marc
    Epelbaum, Jacques
    le Bouc, Yves
    Hanon, Olivier
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12): : 4673 - 4681
  • [44] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma
    Park, Sungshim Lani
    Setiawan, Veronica Wendy
    Kanetsky, Peter A.
    Zhang, Zuo-Feng
    Wilkens, Lynne R.
    Kolonel, Laurence N.
    Le Marchand, Loic
    CANCER CAUSES & CONTROL, 2011, 22 (09) : 1267 - 1275
  • [45] CHARACTERIZATION OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 IN CHRONIC-RENAL-FAILURE SERUM
    POWELL, DR
    LIU, F
    BAKER, B
    LEE, PDK
    BELSHA, CW
    BREWER, ED
    HINTZ, RL
    PEDIATRIC RESEARCH, 1993, 33 (02) : 136 - 143
  • [46] Protease activity for urinary insulin-like growth factor binding protein-3 is increased in diabetic nephropathy
    Shinada, M
    Akdeniz, A
    Panagiotopoulos, P
    Jerums, G
    Bach, LA
    DIABETOLOGIA, 1999, 42 : A274 - A274
  • [47] Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3
    Pirazzoli, P
    Cacciari, E
    DeIasio, R
    Pittalis, MC
    Dallacasa, P
    Zucchini, S
    Gualandi, S
    Salardi, S
    David, C
    Boschi, S
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1997, 77 (02): : F100 - F104
  • [48] Expression of insulin-like growth factor binding protein-3 in HELLP syndrome
    Li Wei
    Zhou Liping
    Kang Suya
    BMC Pregnancy and Childbirth, 23
  • [49] Expression of insulin-like growth factor binding protein-3 in HELLP syndrome
    Wei, Li
    Liping, Zhou
    Suya, Kang
    BMC PREGNANCY AND CHILDBIRTH, 2023, 23 (01)
  • [50] Insulin-like growth factor binding protein-3 in patients with liver cirrhosis.
    Prusa, R
    Sidlova, K
    Lany, J
    Pechova, M
    CLINICAL CHEMISTRY, 2001, 47 (06) : A28 - A28